z-logo
open-access-imgOpen Access
Use of Selective Serotonin Reuptake Inhibitors and Sleep Quality: A Population-Based Study
Author(s) -
Nikkie Aarts,
Lisette A. Zuurbier,
Raymond Noordam,
Albert Hofman,
Henning Tiemeier,
Bruno H. Stricker,
Loes E. Visser
Publication year - 2016
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.5932
Subject(s) - pittsburgh sleep quality index , medicine , rotterdam study , population , confidence interval , depression (economics) , sleep (system call) , antidepressant , psychiatry , insomnia , sleep quality , environmental health , macroeconomics , computer science , hippocampus , economics , operating system
Poor sleep is a risk factor for the development and recurrence of depression. Selective serotonin reuptake inhibitor (SSRI) use is consistently associated with good subjective sleep in clinically depressed patient populations. However, studies in the general population are lacking. Our objective was to investigate the association between SSRIs and subjective sleep in a middle-aged and elderly population in a daily practice setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom